Experienced in Lactic Acidosis

Dr. Jesus O. Navarro

Nephrology
National Kidney Partners Llp
14134 Nephron Ln, 
Hudson, FL 
Accepting New Patients
Offers Telehealth
Experienced in Lactic Acidosis
National Kidney Partners Llp
14134 Nephron Ln, 
Hudson, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jesus Navarro is a Nephrologist in Hudson, Florida. Dr. Navarro is rated as an Experienced provider by MediFind in the treatment of Lactic Acidosis. His top areas of expertise are Acute Kidney Failure, End-Stage Renal Disease (ESRD), Nephrosclerosis, and Chronic Kidney Disease. Dr. Navarro is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Nephrology
Licenses
Specialist in FL
Hospital Affiliations
St Josephs Hospital
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

NATIONAL KIDNEY PARTNERS LLP
14134 Nephron Ln, Hudson, FL 34667

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 1/2, Multicenter Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy
A Phase 1/2, Multicenter Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Drug
Study Drug: BION-1301
Study Phase: Phase 1/Phase 2
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
Enrollment Status: Active_not_recruiting
Publish Date: July 18, 2024
Intervention Type: Device, Other
Study Phase: Not Applicable
A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients With Uncontrolled Gout Who Have Undergone Kidney Transplantation
A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients With Uncontrolled Gout Who Have Undergone Kidney Transplantation
Enrollment Status: Completed
Publish Date: June 26, 2024
Intervention Type: Biological
Study Drug: Pegloticase
Study Phase: Phase 4
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients With Enteric Hyperoxaluria
A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients With Enteric Hyperoxaluria
Enrollment Status: Completed
Publish Date: March 08, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Drugs: Gepotidacin, Nitrofurantoin
Study Phase: Phase 3
A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects With Autosomal Dominant Polycystic Kidney Disease
A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Drug: Tesevatinib
Study Phase: Phase 2
View 6 Less Clinical Trials

1 Total Publications

Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment.
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment.
Journal: Clinical pharmacology and therapeutics
Published: March 15, 2022
Similar Doctors
Advanced in Lactic Acidosis
Dr. Elias Doumit
Nephrology
Advanced in Lactic Acidosis
Dr. Elias Doumit
Nephrology

University Medical Service Association Inc

13330 Usf Laurel Dr, 
Tampa, FL 
 (26.2 miles away)
Languages Spoken:
English, Arabic, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Elias Doumit is a Nephrologist in Tampa, Florida. Dr. Doumit is rated as an Advanced provider by MediFind in the treatment of Lactic Acidosis. His top areas of expertise are Respiratory Acidosis, Metabolic Acidosis, Chronic Kidney Disease, and Juvenile Paget's Disease. Dr. Doumit is currently accepting new patients.

Advanced in Lactic Acidosis
Dr. Jacques A. Durr
Nephrology
Advanced in Lactic Acidosis
Dr. Jacques A. Durr
Nephrology

University Medical Service Association Inc

12902 Usf Magnolia Dr, Suite 62, 
Tampa, FL 
 (26.4 miles away)
813-821-8038
Languages Spoken:
English, French, German, Italian
See accepted insurances
Accepting New Patients

Jacques Durr is a Nephrologist in Tampa, Florida. Dr. Durr is rated as an Advanced provider by MediFind in the treatment of Lactic Acidosis. His top areas of expertise are Chronic Kidney Disease, Acute Kidney Failure, End-Stage Renal Disease (ESRD), and Respiratory Acidosis. Dr. Durr is currently accepting new patients.

Advanced in Lactic Acidosis
Dr. Smita Padala
Nephrology
Advanced in Lactic Acidosis
Dr. Smita Padala
Nephrology

Padala Family Practice PLLC

2063 N Lecanto Hwy, Suite 1, 
Lecanto, FL 
 (38.8 miles away)
352-436-4428
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Smita Padala is a Nephrologist in Lecanto, Florida. Dr. Padala is rated as an Advanced provider by MediFind in the treatment of Lactic Acidosis. Her top areas of expertise are Acute Kidney Failure, Low Sodium Level, High Potassium Level, and Necrosis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Navarro's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile